Gene · 57007
Papers3,960
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,960
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Control of G protein-coupled receptor function via membrane-interacting intrinsically disordered C-terminal domains. | bioRxiv | 2024 | 37645938 | PubTator, text mining | PubMed |
| Non-neoplastic astrocytes: key players for brain tumor progression. | Front Cell Neurosci | 2023 | 38293652 | PubTator, text mining | PubMed |
| Comprehensive analysis of an endoplasmic reticulum stress-related gene prediction model and immune infiltration in idiopathic pulmonary fibrosis. | Front Immunol | 2023 | 38274787 | PubTator, text mining | PubMed |
| The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer. | Front Oncol | 2023 | 38273859 | PubTator, text mining | PubMed |
| OTUB1-mediated inhibition of ubiquitination: a growing list of effectors, multiplex mechanisms, and versatile functions. | Front Mol Biosci | 2023 | 38264570 | PubTator, text mining | PubMed |
| Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers. | Front Endocrinol (Lausanne) | 2023 | 38260135 | PubTator, text mining | PubMed |
| Harnessing Immunity to Treat Advanced Thyroid Cancer. | Vaccines (Basel) | 2023 | 38250858 | PubTator, text mining | PubMed |
| Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions. | Front Oncol | 2023 | 38250553 | PubTator, text mining | PubMed |
| Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity? | J Pers Med | 2023 | 38248751 | PubTator, text mining | PubMed |
| Prediction of immune infiltration and prognosis for patients with gastric cancer based on the immune-related genes signature. | Heliyon | 2023 | 38213590 | PubTator, text mining | PubMed |
| Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions. | Cancers (Basel) | 2023 | 38201481 | PubTator, text mining | PubMed |
| The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies. | Int J Mol Sci | 2023 | 38139154 | PubTator, text mining | PubMed |
| Deep-Sea Sponges and Corals off the Western Coast of Florida-Intracellular Mechanisms of Action of Bioactive Compounds and Technological Advances Supporting the Drug Discovery Pipeline. | Mar Drugs | 2023 | 38132936 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking Explore the Mechanism of Mubiezi-Yinyanghuo Herb Pair in the Treatment of Rheumatoid Arthritis. | Evid Based Complement Alternat Med | 2023 | 38106514 | PubTator, text mining | PubMed |
| Latent inter-organ mechanism of idiopathic pulmonary fibrosis unveiled by a generative computational approach. | Sci Rep | 2023 | 38081956 | PubTator, text mining | PubMed |
| Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance? | Front Immunol | 2023 | 38077395 | PubTator, text mining | PubMed |
| Bile acid signalling and its role in anxiety disorders. | Front Endocrinol (Lausanne) | 2023 | 38075046 | PubTator, text mining | PubMed |
| New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay. | Front Neurol | 2023 | 38073648 | PubTator, text mining | PubMed |
| Unravelling the mechanism of neurotensin recognition by neurotensin receptor 1. | Nat Commun | 2023 | 38071229 | PubTator, text mining | PubMed |
| Correction: del Molino del Barrio et al. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12. Int. J. Mol. Sci. 2018, 19, 3592. | Int J Mol Sci | 2023 | 38069447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57007/papers?page=13